Now I have all the information I need. Let me produce the final consolidated review.

---

## Summary

This paper proposes EquiRNA, a hierarchical equivariant GNN for RNA structure evaluation that addresses size generalization (training on smaller RNAs, testing on larger ones) by reusing nucleotide representations across a three-level (atom, subunit, nucleotide) message-passing architecture. The authors also introduce a new rRNAsolo dataset with a wider size range than the existing ARES benchmark and a size-insensitive K-nearest neighbor sampling strategy. Empirical results show EquiRNA outperforming baselines including ARES, PaxNet, and EGNN on both datasets.

## Strengths

- **Novel dataset (rRNAsolo) for size generalization in RNA evaluation**: The authors construct a new benchmark with RNAs partitioned by size (50–100 nt training, 100–200 nt test/validation), using TM-score clustering to prevent data leakage. The dataset is substantially larger (~80k/6k/6k candidate structures from 200/15/15 RNAs) and covers a wider size range than ARES, which has only three test RNAs over 100 nt. This is a genuine community resource.

- **Conceptually well-motivated hierarchical design**: The idea of reusing nucleotide representations — the common building block across RNA sizes — across three levels of equivariant message passing (atom-level → subunit-level → nucleotide-level) is biologically grounded and directly targets the size generalization problem. The ablation study (Table 4) confirms that all three levels contribute to performance, with the nucleotide level being the most critical.

- **Strong empirical performance**: On rRNAsolo (Table 1), EquiRNA achieves the best Mean/Median RMSD and relative error across all metrics, with improvements of up to 2.00 in Mean RMSD and 13–17% in relative error over the next best baseline. On ARES (Table 2), EquiRNA also outperforms prior SOTA methods including ARES itself across all four metrics. The Relative Ranking metric (Table 3) confirms consistent superiority on both datasets.

## Weaknesses

### Fatal
None.

### Major

- **Core method section (Section 3.3) is critically under-described**. The section consists of only three high-level sentences stating that EquiRNA uses "three-level E(3)-equivariant processes: atom-level, subunit-level and nucleotide-level." There are **no equations, no message-passing update rules, no description of how equivariance is maintained across levels, no specification of how the KNN strategy operates, and no algorithmic pseudocode**. While Figure 3 provides a schematic, it does not substitute for a mathematical specification. This is a methods paper whose method is not described. Without this information, the contribution cannot be fully evaluated for novelty or correctness, and the work is not reproducible from the text. *(Note: some equations may have been lost during PDF-to-text extraction, but even accounting for that, the textual description is insufficient.)*

- **No statistical significance or confidence intervals reported**. All main results (Tables 1, 2) and ablation studies (Table 4) are reported as point estimates with no variance across runs or random seeds. With only 15 test RNAs, small differences between methods may not be meaningful. The paper claims "significant improvements" but provides no statistical test (e.g., paired bootstrap, Wilcoxon) to support this claim.

### Minor

- **Size generalization regime is narrow**. The paper equates "size generalization" with training on 50–100 nt and testing on 100–200 nt. This is a 2× size shift for a single split. The paper does not discuss or test whether the method would generalize to RNAs >200 nt or <50 nt, nor does it test multiple training-size regimes. The claim of "size-generalizable" in the title/abstract is broader than what is demonstrated (the paper does acknowledge this is "an initial exploration").

- **Ablation of equivariance is under-specified**. The "w/o Eq" ablation replaces equivariant layers with invariant ones, but the paper does not describe what was concretely changed — whether coordinate features were dropped entirely, whether scalarization was removed, etc. This makes it difficult to interpret what this ablation actually measures.

- **Complexity claims are unquantified**. The paper states EquiRNA "costs much less inference time than ARES" and is "faster than EGNN" (Section 4.1), but provides no runtime measurements, FLOP counts, or wall-clock comparisons. These claims cannot be verified.

- **No analysis of failure cases or sensitivity to K in KNN**. The size-insensitive KNN strategy is presented as a key contribution, yet there is no sweep over K values or analysis of how K affects performance on RNAs of different sizes. Similarly, the paper does not examine cases where EquiRNA underperforms baselines.

### Trivial
- The claim in Section 3.2 that "Our rRNAsolo exhibits the following advantages" appears mid-sentence (line 51) after a dangling citation, suggesting minor editing issues.

## Nice-to-Haves
- Cross-dataset transfer experiments (train on rRNAsolo, test on ARES and vice versa) would strengthen the generalization claims.
- Scatter plots of predicted vs. native RMSD across all candidates for individual test RNAs would help visualize scoring quality beyond top-1 selection.
- Sequence diversity statistics (number of unique RNA families) for rRNAsolo would help assess dataset coverage.

## Removed Points
- *"Existing GeoGNN claim is vague"* — The paper specifically cites PaxNet's loss of directional information and ARES's high computational cost from high-degree irreducible representations (lines 21–26). This is sufficiently concrete.
- *"Baseline hyperparameter tuning"* — Using default configurations for all baselines is standard fair practice and does not disadvantage the baselines. This criticism is removed per the rule about asymmetry favoring baselines.
- *"Modest size shift (50-100 to 100-200 is only 2x)"* — The paper explicitly scopes this as "an initial exploration" (line 19). For RNA structure evaluation, this is a non-trivial regime given data scarcity for large structures (Fig. 2 shows only 3.6% of high-resolution RNAs are >100 nt).
- *Strength Finder's generic strengths* — Some claimed strengths (e.g., "comprehensive ablation studies validate each design choice") are kept but contextualized within the limitations noted above.
- *"Dataset size is small (200/15/15 RNAs)"* — This is standard for the domain (ARES uses 14/4/16 RNAs for train/val/test). The number of candidate structures (80k/6k/6k) is substantial.

## Novel Insights
None beyond the paper's own contributions. The reviews do not surface a perspective that meaningfully reframes or extends the paper's core findings.

## Suggestions

1. **Substantially expand Section 3.3** with full equations for the three-level message passing, formal definitions of the KNN strategy, and algorithmic pseudocode. Without this, the paper's primary contribution cannot be assessed.
2. **Report results with confidence intervals or standard deviations** across multiple random seeds (at least 3–5) for all main tables. Given the small test set, a statistical test (e.g., Wilcoxon signed-rank) comparing EquiRNA against each baseline would substantiate the "significant improvement" claims.
3. **Provide quantitative runtime comparisons** (wall-clock time per RNA or per candidate) for EquiRNA vs. EGNN vs. ARES to support the complexity claims.
4. **Include a sensitivity analysis** for the K parameter in the size-insensitive KNN strategy, varying K across a range and reporting performance on different RNA size intervals.

## Score and Decision

The paper has genuine contributions (the rRNAsolo dataset is a useful resource, the conceptual hierarchical design is well-motivated, and the empirical results are strong). However, the core method section lacks sufficient technical detail to evaluate novelty, correctness, or reproducibility — a critical flaw for a methods paper. The experimental evaluation also lacks statistical rigor. These issues cannot be fully resolved in a rebuttal as they require rewriting the method section and re-running experiments with multiple seeds.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>